Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects

被引:57
作者
Naniche, D
Garenne, M
Rae, C
Manchester, M
Buchta, R
Brodine, SK
Oldstone, MBA
机构
[1] Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Ctr Integrat Mol Biosci, Dept Cell Biol, La Jolla, CA 92037 USA
[3] Scripps Clin, Dept Pediat, La Jolla, CA USA
[4] San Diego State Univ, Div Epidemiol, Sch Publ Hlth, San Diego, CA 92182 USA
[5] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France
关键词
D O I
10.1086/424571
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since the licensure and generalization of an effective measles virus (MV) vaccine 41 years ago, antibody levels have been used as correlates of immunity. The long-lived MV-specific antibody response has been studied intensely, but the dynamics of MV-specific T cell immunity over time have not been well characterized. We thus characterized the profiles of MV vaccine-induced antigen-specific T cells over time since vaccination. In a cross-sectional study of healthy subjects with a history of MV vaccination, we found that MV-specific CD4 and CD8 T cells could be detected up to 34 years after vaccination. The levels of MV-specific CD8 T cells and MV-specific IgG remained stable, whereas the level of MV-specific CD4 T cells decreased significantly in subjects who had been vaccinated >21 years earlier. These results show that MV-specific T cell immunity after vaccination is long lasting and reveal different dynamics between CD4 and CD8 cells after vaccination.
引用
收藏
页码:1387 / 1395
页数:9
相关论文
共 58 条
[51]   Expression of interleukin-2 receptor α and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees [J].
Toyoda, M ;
Ihara, T ;
Nakano, T ;
Ito, M ;
Kamiya, H .
VACCINE, 1999, 17 (15-16) :2051-2058
[52]   CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge [J].
vonHerrath, MG ;
Yokoyama, M ;
Dockter, J ;
Oldstone, MBA ;
Whitton, JL .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1072-1079
[53]   CELLULAR-IMMUNITY IN MEASLES-VACCINE FAILURE - DEMONSTRATION OF MEASLES ANTIGEN-SPECIFIC LYMPHOPROLIFERATIVE RESPONSES DESPITE LIMITED SERUM ANTIBODY-PRODUCTION AFTER REVACCINATION [J].
WARD, BJ ;
BOULIANNE, N ;
RATNAM, S ;
GUIOT, MC ;
COUILLARD, M ;
DESERRES, G .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1591-1595
[54]  
WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669
[55]  
WEIBEL RE, 1980, P SOC EXP BIOL MED, V165, P260, DOI 10.3181/00379727-165-40967
[56]   Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines [J].
Whittle, H ;
Aaby, P ;
Samb, B ;
Cissé, B ;
Kanteh, F ;
Soumaré, M ;
Jensen, H ;
Bennett, J ;
Simondon, F .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (01) :53-57
[57]  
*WHO, 1993, WHOEPIGEN9817
[58]   MEASLES VIRUS-SPECIFIC CELLULAR-IMMUNITY IN PATIENTS WITH VACCINE FAILURE [J].
WU, VH ;
MCFARLAND, H ;
MAYO, K ;
HANGER, L ;
GRIFFIN, DE ;
DHIBJALBUT, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (01) :118-122